MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1

被引:26
|
作者
Huang, Hui [1 ]
Xiong, Ying [2 ]
Wu, Zhensheng [1 ]
He, Yuhui [1 ]
Gao, Xianglin [1 ]
Zhou, Zhangyan [2 ]
Wang, Tao [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Shunde Hosp, Dept Urol, A163 Lecong Ave, Foshan, Guangdong, Peoples R China
[2] Yangtze Univ, Affiliated Hosp 1, Dept Urol, Jingzhou, Peoples R China
来源
关键词
FOXC1; MIR-138-5P; prostate cancer; tumor suppressor gene; MIGRATION; MICRORNA; INVASION;
D O I
10.1002/mgg3.1193
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Studies have suggested that micro-RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR-138-5P (613394) in prostate cancer (PCa) remains unclear. Methods Expression level of MIR-138-5P in PCa cell lines and normal cell line was analyzed with the quantitative real-time PCR method. Cell counting kit-8 assay, colony formation assay, wound-healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR-138-5P. Results We showed MIR-138-5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR-138-5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR-138-5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR-138-5P on PCa cell behaviors. Conclusions Collectively, we showed that MIR-138-5P functions as a tumor suppressor gene in PCa via targeting FOXC1.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
    Dapeng Zhang
    Xiaodong Liu
    Qingwei Zhang
    Xin Chen
    Cancer Cell International, 20
  • [2] miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1
    Zhang, Dapeng
    Liu, Xiaodong
    Zhang, Qingwei
    Chen, Xin
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [3] MiR-138-5p predicts negative prognosis and exhibits suppressive activities in hepatocellular carcinoma HCC by targeting FOXC1
    Yang, G.
    Guo, S.
    Liu, H-T
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (17) : 8788 - 8800
  • [4] MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1
    Wu, Jiaen
    Han, Xuejia
    Yang, Xiancong
    Li, Youjie
    Liang, Yan
    Sun, Guangbin
    Wang, Ranran
    Wang, Pingyu
    Xie, Shuyang
    Feng, Jiankai
    Sun, Hongfang
    THORACIC CANCER, 2023, 14 (06) : 612 - 623
  • [5] WWC1, a target of miR-138-5p, facilitates the progression of prostate cancer
    Liu, Miao
    Liu, Shiguo
    Chen, Feng
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (06): : 772 - 781
  • [6] MiR-138-5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B
    Liu, Lina
    Zhang, Yan
    Hu, Xi
    Zhang, Hui
    Jiang, Chenyang
    Guo, Yan
    Cang, Shundong
    TRANSLATIONAL ONCOLOGY, 2023, 35
  • [7] Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
    Xiaoming Bai
    Jiaofang Shao
    Sujin Zhou
    Zhenggang Zhao
    Fanghong Li
    Rong Xiang
    Allan Z. Zhao
    Jinshun Pan
    Journal of Experimental & Clinical Cancer Research, 38
  • [8] Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
    Bai, Xiaoming
    Shao, Jiaofang
    Zhou, Sujin
    Zhao, Zhenggang
    Li, Fanghong
    Xiang, Rong
    Zhao, Allan Z.
    Pan, Jinshun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (01)
  • [9] miR-138-5p inhibits the progression of colorectal cancer via regulating SP1/LGR5 axis
    Zou, Qing-Tao
    Lin, Yi
    Luo, Qing-Yu
    CELL BIOLOGY INTERNATIONAL, 2023, 47 (01) : 273 - 282
  • [10] MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1
    Yu, Chao
    Wang, Min
    Li, Zhipeng
    Xiao, Jie
    Peng, Feng
    Guo, Xingjun
    Deng, Yazhu
    Jiang, Jianxin
    Sun, Chengyi
    CELLULAR ONCOLOGY, 2015, 38 (03) : 173 - 181